This page is part of the FHIR Specification (v3.2.0: R4 Ballot 1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R4 R3
V3-EntityNamePartQualifierR2.cs.xml

Vocabulary Work Group
Maturity Level: N/A
Ballot Status: Informative
Raw XML (canonical form)
Description: The qualifier is a set of codes each of which specifies a certain subcategory of the name part in addition to the main name part type. For example, a given name may be flagged as a nickname, a family name may be a pseudonym or a name of public records.
<CodeSystem xmlns="http://hl7.org/fhir">
  <id value="v3-EntityNamePartQualifierR2"/> 
  <meta> 
    <lastUpdated value="2017-07-31T00:00:00.000+10:00"/> 
  </meta> 
  <text> 
    <status value="generated"/> 
    <div xmlns="http://www.w3.org/1999/xhtml">
      <p> Release Date: 2017-07-31</p> 

      <table class="grid">
 
        <tr> 
          <td> 
            <b> Level</b> 
          </td> 
          <td> 
            <b> Code</b> 
          </td> 
          <td> 
            <b> Display</b> 
          </td> 
          <td> 
            <b> Definition</b> 
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> AD
            <a name="v3-EntityNamePartQualifierR2-AD"> </a> 
          </td> 
          <td> acquired</td> 
          <td> 
                        
                           Description:A name part a person acquired.  The name part may
               be acquired by adoption, or the person may have chosen to use the name part for some other
               reason.
            <br/>  

                        
                           Note: this differs from an Other/Psuedonym/Alias in that an
               acquired name part is acquired on a formal basis rather than an informal one (e.g. registered
               as part of the official name).
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 2</td> 
          <td>   SP
            <a name="v3-EntityNamePartQualifierR2-SP"> </a> 
          </td> 
          <td> spouse</td> 
          <td> 
                        
                           Description:The name assumed from the partner in a marital
               relationship.  Usually the spouse's family name.  Note that no inference about gender
               can be made from the existence of spouse names.
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> BR
            <a name="v3-EntityNamePartQualifierR2-BR"> </a> 
          </td> 
          <td> birth</td> 
          <td> 
                        
                           Description:A name that a person was given at birth or established
               as a consequence of adoption. 
            <br/>  

                        
                           Note: This is not used for temporary names assigned at birth
               such as &quot;Baby of Smith&quot; a&quot; which is just a name with a use code of &quot;TEMP&quot;.
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> CL
            <a name="v3-EntityNamePartQualifierR2-CL"> </a> 
          </td> 
          <td> callme</td> 
          <td> 
                        
                           Description:Used to indicate which of the various name parts
               is used when interacting with the person.
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> IN
            <a name="v3-EntityNamePartQualifierR2-IN"> </a> 
          </td> 
          <td> initial</td> 
          <td> 
                        
                           Description:Indicates that a name part is just an initial.
                Initials do not imply a trailing period since this would not work with non-Latin scripts.
                In some languages, initials may consist of more than one letter, e.g., &quot;Ph&quot;
               could stand for &quot;Philippe&quot; or &quot;Th&quot; For &quot;Thomas&quot;.
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> LS
            <a name="v3-EntityNamePartQualifierR2-LS"> </a> 
          </td> 
          <td> legal status</td> 
          <td> 
                        
                           Description:For organizations a suffix indicating the legal
               status, e.g., &quot;Inc.&quot;, &quot;Co.&quot;, &quot;AG&quot;, &quot;GmbH&quot;, &quot;B.V.&quot;
               &quot;S.A.&quot;, &quot;Ltd.&quot; etc.
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> MID
            <a name="v3-EntityNamePartQualifierR2-MID"> </a> 
          </td> 
          <td> middle name</td> 
          <td> 
                        
                           Description:Indicates that the name part is a middle name.
            <br/>  

                        
                           Usage Notes: In general, the english &quot;middle name&quot;
               concept is all of the given names after the first. This qualifier may be used to explicitly
               indicate which given names are considered to be middle names. The middle name qualifier
               may also be used with family names. This is a Scandinavian use case, matching the concept
               of &quot;mellomnavn&quot;,&quot;mellannamn&quot;. Note that there are specific rules that
               indicate what names may be taken as a mellannamn in different Scandinavian countries.
                          
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> PFX
            <a name="v3-EntityNamePartQualifierR2-PFX"> </a> 
          </td> 
          <td> prefix</td> 
          <td> 
                        
                           Description:A prefix has a strong association to the immediately
               following name part. A prefix has no implicit trailing white space (it has implicit leading
               white space though). 
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> 
            <span style="color: grey">
              <i> (PharmaceuticalEntityNamePartQualifiers)</i> 
            </span>  
            <b> 
              <i> Abstract</i> 
            </b> 
          </td> 
          <td> 
            <a name="v3-EntityNamePartQualifierR2-PharmaceuticalEntityNamePartQualifiers"> </a> 
          </td> 
          <td> 
                        
                           Description: Medication Name Parts are a means of specifying
               a range of acceptable &quot;official&quot; forms of the name of a product.  They are used
               as patterns against which input name strings may be matched for automatic identification
               of products from input text reports.   While they cover the concepts held under &quot;doseForm&quot;
               or &quot;route&quot; or &quot;strength&quot; the name parts are not the same and do not
               fit into a controlled vocabulary in the same way. By specifying up to 8 name parts a much
               larger range of possible names can be generated.
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 2</td> 
          <td>   CON
            <a name="v3-EntityNamePartQualifierR2-CON"> </a> 
          </td> 
          <td> container name</td> 
          <td> 
                        
                           Description: This refers to the container if present in the
               medicinal product name.
            <br/>  

                        EXAMPLES: 
            <br/>  

                        
                           
                              For Optaflu suspension for injection in pre-filled syringe
               Influenza vaccine (surface antigen, inactivated, prepared in cell culture) (2007/2008
               season): pre-filled syringe
            <br/>  

                           
                        
                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 2</td> 
          <td>   DEV
            <a name="v3-EntityNamePartQualifierR2-DEV"> </a> 
          </td> 
          <td> device name</td> 
          <td> 
                        
                           Description: This refers to the qualifiers in the name for
               devices and is at the moment mainly applicable to insulins and inhalation products.
            <br/>  

                        EXAMPLES: 
            <br/>  

                        
                           
                              For the medicinal product Actrapid FlexPen 100 IU/ml Solution
               for injection Subcutaneous use: FlexPen.
            <br/>  

                           
                        
                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 2</td> 
          <td>   FLAV
            <a name="v3-EntityNamePartQualifierR2-FLAV"> </a> 
          </td> 
          <td> FlavorName</td> 
          <td> 
                        
                           Description: This refers to a flavor of the medicinal product
               if present in the medicinal product name.
            <br/>  

                        
                           Examples:
                        
            <br/>  

                        
                           For 'CoughCure Linctus Orange Flavor', the flavor part is &quot;Orange&qu
              ot;
                           For 'Wonderdrug Syrup Cherry Flavor', the flavor part is &quot;Cherry&quo
              t;
                        
                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 2</td> 
          <td>   FORMUL
            <a name="v3-EntityNamePartQualifierR2-FORMUL"> </a> 
          </td> 
          <td> FormulationPartName</td> 
          <td> 
                        
                           Description: This refers to the formulation of the medicinal
               product if present in the medicinal product name.
            <br/>  

                        
                           Examples:
                        
            <br/>  

                        
                           For 'SpecialMed Sugar Free Cough Syrup', the formulation name
               part is &quot;Sugar Free&quot;
                           For 'QuickCure Gluten-free Bulk Fibre', the formulation name
               part is &quot;gluten-free&quot;
                        
                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 2</td> 
          <td>   FRM
            <a name="v3-EntityNamePartQualifierR2-FRM"> </a> 
          </td> 
          <td> form name</td> 
          <td> 
                        
                           Description: This refers to the pharmaceutical form/ if present
               in the medicinal product name.
            <br/>  

                        EXAMPLES: 
            <br/>  

                        
                           
                              For Agenerase 50 mg soft capsules: Soft Capsules
            <br/>  

                           
                           
                              For Ludiomil 25mg-Filmtabletten: Filmtabletten
            <br/>  

                           
                           
                              For Optaflu suspension for injection in pre-filled syringe
               Influenza vaccine (surface antigen, inactivated, prepared in cell culture) (2007/2008
               season): suspension for injection
            <br/>  

                           
                        
                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 2</td> 
          <td>   INV
            <a name="v3-EntityNamePartQualifierR2-INV"> </a> 
          </td> 
          <td> invented name</td> 
          <td> 
                        
                           Description: This refers to the product name without the trademark
               or the name of the marketing authorization holder or any other descriptor reflected in
               the product name and, if appropriate, whether it is intended e.g. for babies, children
               or adults. 
            <br/>  

                        EXAMPLES: 
            <br/>  

                        
                           
                              Agenerase
            <br/>  

                           
                           
                              Optaflu
            <br/>  

                           
                           
                              Ludiomil
            <br/>  

                           
                        
                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 2</td> 
          <td>   POPUL
            <a name="v3-EntityNamePartQualifierR2-POPUL"> </a> 
          </td> 
          <td> TargetPopulationName</td> 
          <td> 
                        
                           Description: This refers to the target population for the medicinal
               product if present in the medicinal product name
            <br/>  

                        
                           Examples:
                        
            <br/>  

                        
                           For 'Broncho-Drug 3.5 mg-capsules for children', the target
               population part is &quot;children&quot;
                           For 'Adult Chesty Cough Syrup', the target population part
               is &quot;adult&quot;
                        
                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 2</td> 
          <td>   SCI
            <a name="v3-EntityNamePartQualifierR2-SCI"> </a> 
          </td> 
          <td> scientific name</td> 
          <td> 
                        
                           Description: This refers to the product common or scientific
               name without the trademark or the name of the marketing authorization holder or any other
               descriptor reflected in the product name.
            <br/>  

                        EXAMPLES: 
            <br/>  

                        
                           
                              For Agenerase: N/A
            <br/>  

                           
                           
                              For Optaflu: Influenza vaccine (surface antigen, inactivated,
               prepared in cell culture) (2007/2008 season)
            <br/>  

                           
                           
                              For Ludiomil: N/A
            <br/>  

                           
                        
                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 2</td> 
          <td>   STR
            <a name="v3-EntityNamePartQualifierR2-STR"> </a> 
          </td> 
          <td> strength name</td> 
          <td> 
                        
                           Description: This refers to the strength if present in the
               medicinal product name. The use of decimal points should be accommodated if required.
            <br/>  

                        EXAMPLES:
            <br/>  

                        
                           
                              For Agenerase 50 mg soft capsules: 50mg
            <br/>  

                           
                           
                              For Ludiomil 25mg-Filmtabletten: 25 mg
            <br/>  

                           
                           
                              For Optaflu suspension for injection in pre-filled syringe
               Influenza vaccine (surface antigen, inactivated, prepared in cell culture) (2007/2008
               season): N/A
            <br/>  

                           
                        
                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 2</td> 
          <td>   TIME
            <a name="v3-EntityNamePartQualifierR2-TIME"> </a> 
          </td> 
          <td> TimeOrPeriodName</td> 
          <td> 
                        
                           Description: This refers to a time or time period that may
               be specified in the text of the medicinal product name
            <br/>  

                        
                           Example:
                        
            <br/>  

                        
                           For an influenza vaccine 'Drug-FLU season 2008/2009', the time/period
               part is &quot;2008/2009 season&quot;
                        
                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 2</td> 
          <td>   TMK
            <a name="v3-EntityNamePartQualifierR2-TMK"> </a> 
          </td> 
          <td> trademark name</td> 
          <td> 
                        
                           Description: This refers to trademark/company element if present
               in the medicinal product name.
            <br/>  

                        EXAMPLES: 
            <br/>  

                        
                           
                              for Insulin Human Winthrop Comb 15: Winthrop
            <br/>  

                           
                        
                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 2</td> 
          <td>   USE
            <a name="v3-EntityNamePartQualifierR2-USE"> </a> 
          </td> 
          <td> intended use name</td> 
          <td> 
                        
                           Description: This refers to the intended use if present in
               the medicinal product name without the trademark or the name of the marketing authorization
               holder or any other descriptor reflected in the product name.

            <br/>  

                        
                           Examples:
                        
            <br/>  

                        
                           For 'Drug-BI Caplets - Heartburn Relief', the intended use
               part is: &quot;Heartburn Relief&quot;
                           For 'Medicine Honey Syrup for Soothing Coughs' the intended
               use part is &quot;Soothing Coughs&quot;
                        
                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> SFX
            <a name="v3-EntityNamePartQualifierR2-SFX"> </a> 
          </td> 
          <td> suffix</td> 
          <td> 
                        
                           Description:A suffix has a strong association to the immediately
               preceding name part. A suffix has no implicit leading white space (it has implicit trailing
               white space though).
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> 
            <span style="color: grey">
              <i> (TitleStyles)</i> 
            </span>  
            <b> 
              <i> Abstract</i> 
            </b> 
          </td> 
          <td> 
            <a name="v3-EntityNamePartQualifierR2-TitleStyles"> </a> 
          </td> 
          <td> 
                        
                           Description:Extra information about the style of a title
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 2</td> 
          <td>   AC
            <a name="v3-EntityNamePartQualifierR2-AC"> </a> 
          </td> 
          <td> academic</td> 
          <td> 
                        
                           Description:Indicates that a title like &quot;Dr.&quot;, &quot;M.D.&quot;
               or &quot;Ph.D.&quot; is an academic title.
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 2</td> 
          <td>   HON
            <a name="v3-EntityNamePartQualifierR2-HON"> </a> 
          </td> 
          <td> honorific</td> 
          <td> 
                        
                           Description:A honorific such as &quot;The Right Honourable&quot;
               or &quot;Weledelgeleerde Heer&quot;.
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 2</td> 
          <td>   NB
            <a name="v3-EntityNamePartQualifierR2-NB"> </a> 
          </td> 
          <td> nobility</td> 
          <td> 
                        
                           Description:A nobility title such as Sir, Count, Grafin.
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 2</td> 
          <td>   PR
            <a name="v3-EntityNamePartQualifierR2-PR"> </a> 
          </td> 
          <td> professional</td> 
          <td> 
                        
                           Description:Primarily in the British Imperial culture people
               tend to have an abbreviation of their professional organization as part of their credential
               titles.
            <br/>  

                     
          </td> 
        </tr> 

      </table> 

    </div> 
  </text> 
  <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-ballot-status">
    <valueString value="External"/> 
  </extension> 
  <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm">
    <valueInteger value="0"/> 
  </extension> 
  <url value="http://hl7.org/fhir/v3/EntityNamePartQualifierR2"/> 
  <identifier> 
    <system value="urn:ietf:rfc:3986"/> 
    <value value="urn:oid:2.16.840.1.113883.5.1122"/> 
  </identifier> 
  <version value="2017-07-31"/> 
  <name value="v3 Code System EntityNamePartQualifierR2"/> 
  <status value="active"/> 
  <experimental value="false"/> 
  <date value="2017-07-31T00:00:00+10:00"/> 
  <publisher value="HL7, Inc"/> 
  <contact> 
    <telecom> 
      <system value="url"/> 
      <value value="http://hl7.org"/> 
    </telecom> 
  </contact> 
  <description value="  Description:
The qualifier is a set of codes each of which specifies a certain subcategory of the name
     part in addition to the main name part type. For example, a given name may be flagged
     as a nickname, a family name may be a pseudonym or a name of public records."/> 
  <caseSensitive value="true"/> 
  <valueSet value="http://hl7.org/fhir/ValueSet/v3-EntityNamePartQualifierR2"/> 
  <hierarchyMeaning value="is-a"/> 
  <content value="complete"/> 
  <property> 
    <code value="notSelectable"/> 
    <uri value="http://hl7.org/fhir/concept-properties#notSelectable"/> 
    <description value="Indicates that the code is abstract - only intended to be used as a selector for other
       concepts"/> 
    <type value="boolean"/> 
  </property> 
  <concept> 
    <code value="AD"/> 
    <display value="acquired"/> 
    <definition value="Description:A name part a person acquired.  The name part may be acquired by adoption,
       or the person may have chosen to use the name part for some other reason.

                        
                           Note: this differs from an Other/Psuedonym/Alias in that an
       acquired name part is acquired on a formal basis rather than an informal one (e.g. registered
       as part of the official name)."/> 
    <concept> 
      <code value="SP"/> 
      <display value="spouse"/> 
      <definition value="Description:The name assumed from the partner in a marital relationship.  Usually the
         spouse's family name.  Note that no inference about gender can be made from the existence
         of spouse names."/> 
    </concept> 
  </concept> 
  <concept> 
    <code value="BR"/> 
    <display value="birth"/> 
    <definition value="Description:A name that a person was given at birth or established as a consequence of
       adoption. 

                        
                           Note: This is not used for temporary names assigned at birth
       such as &quot;Baby of Smith&quot; a&quot; which is just a name with a use code of &quot;TEMP&quot;."/> 
  </concept> 
  <concept> 
    <code value="CL"/> 
    <display value="callme"/> 
    <definition value="Description:Used to indicate which of the various name parts is used when interacting
       with the person."/> 
  </concept> 
  <concept> 
    <code value="IN"/> 
    <display value="initial"/> 
    <definition value="Description:Indicates that a name part is just an initial.  Initials do not imply a trailing
       period since this would not work with non-Latin scripts.  In some languages, initials
       may consist of more than one letter, e.g., &quot;Ph&quot; could stand for &quot;Philippe&quot;
       or &quot;Th&quot; For &quot;Thomas&quot;."/> 
  </concept> 
  <concept> 
    <code value="LS"/> 
    <display value="legal status"/> 
    <definition value="Description:For organizations a suffix indicating the legal status, e.g., &quot;Inc.&quot;,
       &quot;Co.&quot;, &quot;AG&quot;, &quot;GmbH&quot;, &quot;B.V.&quot; &quot;S.A.&quot;,
       &quot;Ltd.&quot; etc."/> 
  </concept> 
  <concept> 
    <code value="MID"/> 
    <display value="middle name"/> 
    <definition value="Description:Indicates that the name part is a middle name.

                        
                           Usage Notes: In general, the english &quot;middle name&quot;
       concept is all of the given names after the first. This qualifier may be used to explicitly
       indicate which given names are considered to be middle names. The middle name qualifier
       may also be used with family names. This is a Scandinavian use case, matching the concept
       of &quot;mellomnavn&quot;,&quot;mellannamn&quot;. Note that there are specific rules that
       indicate what names may be taken as a mellannamn in different Scandinavian countries."/> 
  </concept> 
  <concept> 
    <code value="PFX"/> 
    <display value="prefix"/> 
    <definition value="Description:A prefix has a strong association to the immediately following name part.
       A prefix has no implicit trailing white space (it has implicit leading white space though)."/> 
  </concept> 
  <concept> 
    <code value="PharmaceuticalEntityNamePartQualifiers"/> 
    <display value="PharmaceuticalEntityNamePartQualifiers"/> 
    <definition value="Description: Medication Name Parts are a means of specifying a range of acceptable &quot;official&qu
      ot; forms of the name of a product.  They are used as patterns against which input name
       strings may be matched for automatic identification of products from input text reports.
         While they cover the concepts held under &quot;doseForm&quot; or &quot;route&quot; or
       &quot;strength&quot; the name parts are not the same and do not fit into a controlled
       vocabulary in the same way. By specifying up to 8 name parts a much larger range of possible
       names can be generated."/> 
    <property> 
      <code value="notSelectable"/> 
      <valueBoolean value="true"/> 
    </property> 
    <concept> 
      <code value="CON"/> 
      <display value="container name"/> 
      <definition value="Description: This refers to the container if present in the medicinal product name.

                        EXAMPLES: 

                        
                           
                              For Optaflu suspension for injection in pre-filled syringe
         Influenza vaccine (surface antigen, inactivated, prepared in cell culture) (2007/2008
         season): pre-filled syringe"/> 
    </concept> 
    <concept> 
      <code value="DEV"/> 
      <display value="device name"/> 
      <definition value="Description: This refers to the qualifiers in the name for devices and is at the moment
         mainly applicable to insulins and inhalation products.

                        EXAMPLES: 

                        
                           
                              For the medicinal product Actrapid FlexPen 100 IU/ml Solution
         for injection Subcutaneous use: FlexPen."/> 
    </concept> 
    <concept> 
      <code value="FLAV"/> 
      <display value="FlavorName"/> 
      <definition value="Description: This refers to a flavor of the medicinal product if present in the medicinal
         product name.

                        
                           Examples:
                        

                        
                           For 'CoughCure Linctus Orange Flavor', the flavor part is &quot;Orange&qu
        ot;
                           For 'Wonderdrug Syrup Cherry Flavor', the flavor part is &quot;Cherry&quo
        t;"/> 
    </concept> 
    <concept> 
      <code value="FORMUL"/> 
      <display value="FormulationPartName"/> 
      <definition value="Description: This refers to the formulation of the medicinal product if present in the
         medicinal product name.

                        
                           Examples:
                        

                        
                           For 'SpecialMed Sugar Free Cough Syrup', the formulation name
         part is &quot;Sugar Free&quot;
                           For 'QuickCure Gluten-free Bulk Fibre', the formulation name
         part is &quot;gluten-free&quot;"/> 
    </concept> 
    <concept> 
      <code value="FRM"/> 
      <display value="form name"/> 
      <definition value="Description: This refers to the pharmaceutical form/ if present in the medicinal product
         name.

                        EXAMPLES: 

                        
                           
                              For Agenerase 50 mg soft capsules: Soft Capsules

                           
                           
                              For Ludiomil 25mg-Filmtabletten: Filmtabletten

                           
                           
                              For Optaflu suspension for injection in pre-filled syringe
         Influenza vaccine (surface antigen, inactivated, prepared in cell culture) (2007/2008
         season): suspension for injection"/> 
    </concept> 
    <concept> 
      <code value="INV"/> 
      <display value="invented name"/> 
      <definition value="Description: This refers to the product name without the trademark or the name of the
         marketing authorization holder or any other descriptor reflected in the product name and,
         if appropriate, whether it is intended e.g. for babies, children or adults. 

                        EXAMPLES: 

                        
                           
                              Agenerase

                           
                           
                              Optaflu

                           
                           
                              Ludiomil"/> 
    </concept> 
    <concept> 
      <code value="POPUL"/> 
      <display value="TargetPopulationName"/> 
      <definition value="Description: This refers to the target population for the medicinal product if present
         in the medicinal product name

                        
                           Examples:
                        

                        
                           For 'Broncho-Drug 3.5 mg-capsules for children', the target
         population part is &quot;children&quot;
                           For 'Adult Chesty Cough Syrup', the target population part
         is &quot;adult&quot;"/> 
    </concept> 
    <concept> 
      <code value="SCI"/> 
      <display value="scientific name"/> 
      <definition value="Description: This refers to the product common or scientific name without the trademark
         or the name of the marketing authorization holder or any other descriptor reflected in
         the product name.

                        EXAMPLES: 

                        
                           
                              For Agenerase: N/A

                           
                           
                              For Optaflu: Influenza vaccine (surface antigen, inactivated,
         prepared in cell culture) (2007/2008 season)

                           
                           
                              For Ludiomil: N/A"/> 
    </concept> 
    <concept> 
      <code value="STR"/> 
      <display value="strength name"/> 
      <definition value="Description: This refers to the strength if present in the medicinal product name. The
         use of decimal points should be accommodated if required.

                        EXAMPLES:

                        
                           
                              For Agenerase 50 mg soft capsules: 50mg

                           
                           
                              For Ludiomil 25mg-Filmtabletten: 25 mg

                           
                           
                              For Optaflu suspension for injection in pre-filled syringe
         Influenza vaccine (surface antigen, inactivated, prepared in cell culture) (2007/2008
         season): N/A"/> 
    </concept> 
    <concept> 
      <code value="TIME"/> 
      <display value="TimeOrPeriodName"/> 
      <definition value="Description: This refers to a time or time period that may be specified in the text of
         the medicinal product name

                        
                           Example:
                        

                        
                           For an influenza vaccine 'Drug-FLU season 2008/2009', the time/period
         part is &quot;2008/2009 season&quot;"/> 
    </concept> 
    <concept> 
      <code value="TMK"/> 
      <display value="trademark name"/> 
      <definition value="Description: This refers to trademark/company element if present in the medicinal product
         name.

                        EXAMPLES: 

                        
                           
                              for Insulin Human Winthrop Comb 15: Winthrop"/> 
    </concept> 
    <concept> 
      <code value="USE"/> 
      <display value="intended use name"/> 
      <definition value="Description: This refers to the intended use if present in the medicinal product name
         without the trademark or the name of the marketing authorization holder or any other descriptor
         reflected in the product name.


                        
                           Examples:
                        

                        
                           For 'Drug-BI Caplets - Heartburn Relief', the intended use
         part is: &quot;Heartburn Relief&quot;
                           For 'Medicine Honey Syrup for Soothing Coughs' the intended
         use part is &quot;Soothing Coughs&quot;"/> 
    </concept> 
  </concept> 
  <concept> 
    <code value="SFX"/> 
    <display value="suffix"/> 
    <definition value="Description:A suffix has a strong association to the immediately preceding name part.
       A suffix has no implicit leading white space (it has implicit trailing white space though)."/> 
  </concept> 
  <concept> 
    <code value="TitleStyles"/> 
    <display value="TitleStyles"/> 
    <definition value="Description:Extra information about the style of a title"/> 
    <property> 
      <code value="notSelectable"/> 
      <valueBoolean value="true"/> 
    </property> 
    <concept> 
      <code value="AC"/> 
      <display value="academic"/> 
      <definition value="Description:Indicates that a title like &quot;Dr.&quot;, &quot;M.D.&quot; or &quot;Ph.D.&quot;
         is an academic title."/> 
    </concept> 
    <concept> 
      <code value="HON"/> 
      <display value="honorific"/> 
      <definition value="Description:A honorific such as &quot;The Right Honourable&quot; or &quot;Weledelgeleerde
         Heer&quot;."/> 
    </concept> 
    <concept> 
      <code value="NB"/> 
      <display value="nobility"/> 
      <definition value="Description:A nobility title such as Sir, Count, Grafin."/> 
    </concept> 
    <concept> 
      <code value="PR"/> 
      <display value="professional"/> 
      <definition value="Description:Primarily in the British Imperial culture people tend to have an abbreviation
         of their professional organization as part of their credential titles."/> 
    </concept> 
  </concept> 
</CodeSystem>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.